AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $15K to $50K in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- -$15K to -$50K netNet selling
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 4 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 26- Open
- $78.97
- 52-wk high
- $90.87
- High
- $78.98
- 52-wk low
- $59.97
- Low
- $77.33
- Prev close
- $79.45
- Mkt cap
- $52.39B
- P/E
- 47.6x
- Volume
- 4.16M
- Fwd P/E
- 19.1x
- Beta
- 0.58
- Div yield
- 0.91%
- P/S
- 2.9x
- P/B
- 2.1x
- Profit margin
- +5.7%
- Op margin
- +30.1%
- ROE
- +4.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CTVA filings
Are insiders buying or selling Corteva Inc (CTVA) stock?
Neither. Corteva Inc (CTVA) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded CTVA recently?
Sen. Gary C Peters (D) sold $15K to $50K on Apr 23, 2026, disclosed 18 days later. In total, 1 member disclosed 1 CTVA trade with trade dates in the last 180 days, filed a median 18 days after trading.
How current is this CTVA smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (3)
- BA
Balyasny
$152.0M
added
- MI
Millennium
$61.8M
added
- CI
Citadel
$57.7M
added
What Congress is doing
Sells (1)
How top traders are positioned
No tracked top-trader positions in CTVA right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 2.7% above what analysts expected.
Earnings per share
$2.24 expected
Revenue
No comparable estimate
Reports Nov 3, 2026, in 37 days
Estimates as of Sep 26, 2026
EPS expected
-$0.55 to -$0.15
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.46B | $2.62B | $3.91B | $4.91B |
| Cost of what it sold | $2.93B | $1.64B | $2.25B | $2.37B |
| Gross profit | $3.52B | $974.0M | $1.66B | $2.53B |
| What it spent | ||||
| Research and development | $375.0M | $351.0M | $413.0M | $341.0M |
| Sales and admin | $1.16B | $731.0M | $842.0M | $877.0M |
| Other operating costs | $161.0M | $162.0M | $159.0M | $160.0M |
| Total operating expenses | $1.69B | $1.24B | $1.41B | $1.38B |
| What was left | ||||
| Operating profit | $1.83B | -$270.0M | $242.0M | $1.16B |
| Interest on debt | $52.0M | $46.0M | $46.0M | $36.0M |
| Profit before tax | $1.80B | -$370.0M | -$530.0M | $858.0M |
| Tax | $422.0M | -$62.0M | $7.0M | $133.0M |
| Net profit | $1.31B | -$320.0M | -$552.0M | $720.0M |
| EBITDA | $2.16B | -$24.0M | -$178.0M | $1.19B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace